Inventor · disambiguated record
Peter Soderman
Also filed as: SODERMAN PETER · SOEDERMAN PETER · SÖDERMAN PETER
14 granted patents·12 pending applications·88 citations·filing 2003–2018
92Inventor score
Top patents by PatentIndex Score
26 records- 0190US8865911B2Compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2013·Granted Oct 21, 2014·13 cites·18 claims
- 0288US8415483B2Compounds and their use as BACE inhibitorsCSJERNYIK GABOR·Filed 2011·Granted Apr 9, 2013·14 cites·8 claims
- 0387US9000182B22H-imidazol-4-amine compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2013·Granted Apr 7, 2015·6 cites·7 claims
- 0484US9248129B2Compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2014·Granted Feb 2, 2016·5 cites·16 claims
- 0583US9000185B2Cycloalkyl ether compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2013·Granted Apr 7, 2015·7 cites·7 claims
- 0682US9000184B2Cyclohexane-1,2′-naphthalene-1′,2″-imidazol compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2013·Granted Apr 7, 2015·7 cites·18 claims
- 0782US9000183B2Cyclohexane-1,2′-indene-1′,2″-imidazol compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2013·Granted Apr 7, 2015·7 cites·18 claims
- 0882US7595319B2Compounds having selective inhibiting effect at GSK3ASTRAZENECA AB·Filed 2003·Granted Sep 29, 2009·15 cites·3 claims
- 0981US8030500B2Substituted isoindoles for the treatment and/or prevention of Aβ- related pathologiesASTRAZENECA AB·Filed 2009·Granted Oct 4, 2011·4 cites·2 claims
- 1078US7585853B2Compounds having selective inhibiting effect at GSK3ASTRAZENECA AB·Filed 2003·Granted Sep 8, 2009·9 cites·2 claims
- 1177US9918985B2Compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2017·Granted Mar 20, 2018·1 cites·4 claims
- 1265US10231967B2Compounds and their use as BACE inhibitorsASTRAZENECA AB·Filed 2018·Granted Mar 19, 2019·0 cites·2 claims
- 1360US2010087396A1Novel Compounds Having Selective Inhibiting Effect at GSK3BERG STEFAN·Filed 2009·Application pending·0 cites
- 1460US2010081660A1Novel Compounds Having Selective Inhibiting Effect at GSK3BERG STEFAN·Filed 2009·Application pending·0 cites
- 1560US2010075989A1Novel Compounds Having Selective Inhibiting Effect at GSK3ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1656US2016184303A1Compounds and their use as bace inhibitorsASTRAZENECA AB·Filed 2015·Application pending·0 cites
- 1752US2010125081A1New compounds 574ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1850US2010125087A1New compounds 575ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1947US2008161269A1Compounds 620ASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2045US2011319426A1Substituted IsoindolesHOLENZ JOERG·Filed 2011·Application pending·0 cites
- 2144US2010234593A1Imidazo[4,5-B]Pyridine-7-Carboxamides 704ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2240US2008255085A1Novel Imidazo [4,5-b] Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase 3 for Use in the Treatment of Dementia and Neurodegenerative DisordersASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2340US2008255106A1Novel 2-Phenyl-Imidazo[4,5-B]Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase for the Treatment of Dementia and Neurodegenerative DisordersASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2436US2009018130A1Derivatives of 5-Aryl-1H-Pyrrolo [2, 3B] Pyridine-3-Carboxamide or 5-Aryl-1H-Pyrrolo [2, 3B] Pyridine-3-Carboxylic AcidBERG STEFAN·Filed 2005·Application pending·0 cites
- 2534US10227296B2Bis(sulfonamide) derivatives and their use as mPGES inhibitorsACTURUM REAL ESTATE AB·Filed 2015·Granted Mar 12, 2019·0 cites·25 claims
- 2623US10081614B2Bis(sulfonamide) derivatives and their use as mPGES inhibitorsACTURUM REAL ESTATE AB·Filed 2015·Granted Sep 25, 2018·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →